COGSTATE LTD - Announcements

1.00%

$2.02

Market Cap $345.8M

Healthcare Biotechnology

Cogstate Limited is a neuroscience technology company optimizing brain health assessments... Cogstate Limited is a neuroscience technology company optimizing brain health assessments to advance the development of new medicines and to enable earlier clinical insights in healthcare. Its principal activities are the creation, validation, and commercialization of digital brain health assessments; and design and provision of quality assurance services in clinical trials, focused on the administration, scoring, and recording of conventional brain health assessments. Its segments include Clinical Trials, Healthcare, and Administration. In the Clinical Trials segment, the technology and associated services are used to quantify the effect of disease and of drugs, devices or other interventions on human subjects participating in clinical trials primarily conducted by pharmaceutical, and biotechnology companies. In the Healthcare segment, the technology and associated services are being developed as a tool for primary care physicians and/or hospitals to assess cognitive decline.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile

See benefits

Announcements

Filter Results

All Price Sensitive Only

Filters [Clear]

Price Sensitive: Yes

CGS	CogState signs sales contract for phase 3 study	PRICE SENSITIVE	12/10/12	505.99KB	Share
CGS	Preliminary Final Report	PRICE SENSITIVE	21/08/12	620.47KB	Share
CGS	Appendix 4C - quarterly	PRICE SENSITIVE	27/07/12	1.98MB	Share
CGS	Business update	PRICE SENSITIVE	12/07/12	311.22KB	Share
CGS	CogState partners with Merck Canada	PRICE SENSITIVE	25/06/12	205.77KB	Share
CGS	Appendix 4C - quarterly	PRICE SENSITIVE	26/04/12	1.48MB	Share
CGS	Half Yearly Report and Accounts	PRICE SENSITIVE	21/02/12	7.3MB	Share
CGS	Appendix 4C - quarterly	PRICE SENSITIVE	25/01/12	1.53MB	Share
CGS	CogState Signs Contract For Phase 2 Schizophrenia Study	PRICE SENSITIVE	08/12/11	257.46KB	Share
CGS	CogState signs sales contract for phase 2 study	PRICE SENSITIVE	22/11/11	243.24KB	Share
CGS	CogState signs sales contract for large phase 2 study	PRICE SENSITIVE	16/11/11	249.84KB	Share
CGS	Appendix 4C - quarterly	PRICE SENSITIVE	25/10/11	161.52KB	Share
CGS	Growth in sales contracts delivers strong Q1 results	PRICE SENSITIVE	13/10/11	260.79KB	Share
CGS	CogState signs sales contract for phase 3 study	PRICE SENSITIVE	25/08/11	254.57KB	Share
CGS	Preliminary Final Report	PRICE SENSITIVE	23/08/11	2.72MB	Share
CGS	CogState Acquires 100% Holding of Axon Sports	PRICE SENSITIVE	22/08/11	250.15KB	Share
CGS	Business Update	PRICE SENSITIVE	29/07/11	462.25KB	Share
CGS	Appendix 4C - quarterly	PRICE SENSITIVE	22/07/11	1.56MB	Share
CGS	Business Update - Unaudited Full Year Profit Results	PRICE SENSITIVE	22/07/11	172.96KB	Share
CGS	CogState signs sales contract for large phase 2 study	PRICE SENSITIVE	23/05/11	251.63KB	Share
CGS	CogState announces partnership in area of cognitive training	PRICE SENSITIVE	19/05/11	269.03KB	Share
CGS	CogState Again Used in Successful Schizophrenia Study	PRICE SENSITIVE	18/05/11	154.74KB	Share
CGS	Appendix 4C - quarterly	PRICE SENSITIVE	21/04/11	1.52MB	Share
CGS	CogState Tests Used in Successful Ph 2 Schizophrenia Study	PRICE SENSITIVE	11/04/11	2B	Share
CGS	CogState signs sales contract for phase 3 study	PRICE SENSITIVE	04/04/11	156.16KB	Share
CGS	NRL mandates use of CogState for concussion management	PRICE SENSITIVE	01/04/11	158.47KB	Share
CGS	Half Yearly Report and Accounts	PRICE SENSITIVE	23/02/11	5.05MB	Share
CGS	Appendix 4C - quarterly	PRICE SENSITIVE	28/01/11	225.51KB	Share
CGS	Appendix 4C - quarterly	PRICE SENSITIVE	21/10/10	1.39MB	Share
CGS	CogState 2010 AGM Address	PRICE SENSITIVE	21/10/10	159.62KB	Share
CGS	Launch of Axon Sports	PRICE SENSITIVE	25/08/10	100.87KB	Share
CGS	Preliminary Final Report and Annual Report	PRICE SENSITIVE	24/08/10	8.48MB	Share
CGS	Appendix 4C - quarterly	PRICE SENSITIVE	27/07/10	232.48KB	Share
CGS	Business Update - Unaudited Full Year Profit Results	PRICE SENSITIVE	27/07/10	146.75KB	Share
CGS	JV Agreement Signed	PRICE SENSITIVE	10/06/10	134.19KB	Share
CGS	Appendix 4C - quarterly	PRICE SENSITIVE	28/04/10	225.97KB	Share
CGS	Business Update	PRICE SENSITIVE	28/04/10	148.89KB	Share
CGS	Half Yearly Report and Accounts	PRICE SENSITIVE	23/02/10	1021.6KB	Share
CGS	Appendix 4C - quarterly	PRICE SENSITIVE	27/01/10	219.94KB	Share
CGS	Appendix 4C - quarterly	PRICE SENSITIVE	21/10/09	219.41KB	Share
CGS	CogState Business Update	PRICE SENSITIVE	06/10/09	175.07KB	Share
CGS	Businsess Update	PRICE SENSITIVE	25/08/09	140.92KB	Share
CGS	Appendix 4E and FY09 Annual Report	PRICE SENSITIVE	25/08/09	13.62MB	Share
CGS	Appendix 4C - quarterly	PRICE SENSITIVE	29/07/09	224.43KB	Share
CGS	NPAT - Unaudited	PRICE SENSITIVE	16/07/09	154.77KB	Share
CGS	CogState Contract Signings	PRICE SENSITIVE	25/05/09	133.03KB	Share
CGS	Appendix 4C - quarterly	PRICE SENSITIVE	29/04/09	181.05KB	Share
CGS	Full year profit guidance and Business Update	PRICE SENSITIVE	25/02/09	135.13KB	Share
CGS	Appendix 4D and 31 December 2008 Half Year Financial Report	PRICE SENSITIVE	25/02/09	393.26KB	Share
CGS	Strategic Relationship Update	PRICE SENSITIVE	18/02/09	253.39KB	Share
CGS	Appendix 4C - quarterly	PRICE SENSITIVE	28/01/09	184.69KB	Share

CGSCogState signs sales contract for phase 3 study
12/10/12	PRICE SENSITIVE	505.99KB	Share
CGSPreliminary Final Report
21/08/12	PRICE SENSITIVE	620.47KB	Share
CGSAppendix 4C - quarterly
27/07/12	PRICE SENSITIVE	1.98MB	Share
CGSBusiness update
12/07/12	PRICE SENSITIVE	311.22KB	Share
CGSCogState partners with Merck Canada
25/06/12	PRICE SENSITIVE	205.77KB	Share
CGSAppendix 4C - quarterly
26/04/12	PRICE SENSITIVE	1.48MB	Share
CGSHalf Yearly Report and Accounts
21/02/12	PRICE SENSITIVE	7.3MB	Share
CGSAppendix 4C - quarterly
25/01/12	PRICE SENSITIVE	1.53MB	Share
CGSCogState Signs Contract For Phase 2 Schizophrenia Study
08/12/11	PRICE SENSITIVE	257.46KB	Share
CGSCogState signs sales contract for phase 2 study
22/11/11	PRICE SENSITIVE	243.24KB	Share
CGSCogState signs sales contract for large phase 2 study
16/11/11	PRICE SENSITIVE	249.84KB	Share
CGSAppendix 4C - quarterly
25/10/11	PRICE SENSITIVE	161.52KB	Share
CGSGrowth in sales contracts delivers strong Q1 results
13/10/11	PRICE SENSITIVE	260.79KB	Share
CGSCogState signs sales contract for phase 3 study
25/08/11	PRICE SENSITIVE	254.57KB	Share
CGSPreliminary Final Report
23/08/11	PRICE SENSITIVE	2.72MB	Share
CGSCogState Acquires 100% Holding of Axon Sports
22/08/11	PRICE SENSITIVE	250.15KB	Share
CGSBusiness Update
29/07/11	PRICE SENSITIVE	462.25KB	Share
CGSAppendix 4C - quarterly
22/07/11	PRICE SENSITIVE	1.56MB	Share
CGSBusiness Update - Unaudited Full Year Profit Results
22/07/11	PRICE SENSITIVE	172.96KB	Share
CGSCogState signs sales contract for large phase 2 study
23/05/11	PRICE SENSITIVE	251.63KB	Share
CGSCogState announces partnership in area of cognitive training
19/05/11	PRICE SENSITIVE	269.03KB	Share
CGSCogState Again Used in Successful Schizophrenia Study
18/05/11	PRICE SENSITIVE	154.74KB	Share
CGSAppendix 4C - quarterly
21/04/11	PRICE SENSITIVE	1.52MB	Share
CGSCogState Tests Used in Successful Ph 2 Schizophrenia Study
11/04/11	PRICE SENSITIVE	2B	Share
CGSCogState signs sales contract for phase 3 study
04/04/11	PRICE SENSITIVE	156.16KB	Share
CGSNRL mandates use of CogState for concussion management
01/04/11	PRICE SENSITIVE	158.47KB	Share
CGSHalf Yearly Report and Accounts
23/02/11	PRICE SENSITIVE	5.05MB	Share
CGSAppendix 4C - quarterly
28/01/11	PRICE SENSITIVE	225.51KB	Share
CGSAppendix 4C - quarterly
21/10/10	PRICE SENSITIVE	1.39MB	Share
CGSCogState 2010 AGM Address
21/10/10	PRICE SENSITIVE	159.62KB	Share
CGSLaunch of Axon Sports
25/08/10	PRICE SENSITIVE	100.87KB	Share
CGSPreliminary Final Report and Annual Report
24/08/10	PRICE SENSITIVE	8.48MB	Share
CGSAppendix 4C - quarterly
27/07/10	PRICE SENSITIVE	232.48KB	Share
CGSBusiness Update - Unaudited Full Year Profit Results
27/07/10	PRICE SENSITIVE	146.75KB	Share
CGSJV Agreement Signed
10/06/10	PRICE SENSITIVE	134.19KB	Share
CGSAppendix 4C - quarterly
28/04/10	PRICE SENSITIVE	225.97KB	Share
CGSBusiness Update
28/04/10	PRICE SENSITIVE	148.89KB	Share
CGSHalf Yearly Report and Accounts
23/02/10	PRICE SENSITIVE	1021.6KB	Share
CGSAppendix 4C - quarterly
27/01/10	PRICE SENSITIVE	219.94KB	Share
CGSAppendix 4C - quarterly
21/10/09	PRICE SENSITIVE	219.41KB	Share
CGSCogState Business Update
06/10/09	PRICE SENSITIVE	175.07KB	Share
CGSBusinsess Update
25/08/09	PRICE SENSITIVE	140.92KB	Share
CGSAppendix 4E and FY09 Annual Report
25/08/09	PRICE SENSITIVE	13.62MB	Share
CGSAppendix 4C - quarterly
29/07/09	PRICE SENSITIVE	224.43KB	Share
CGSNPAT - Unaudited
16/07/09	PRICE SENSITIVE	154.77KB	Share
CGSCogState Contract Signings
25/05/09	PRICE SENSITIVE	133.03KB	Share
CGSAppendix 4C - quarterly
29/04/09	PRICE SENSITIVE	181.05KB	Share
CGSFull year profit guidance and Business Update
25/02/09	PRICE SENSITIVE	135.13KB	Share
CGSAppendix 4D and 31 December 2008 Half Year Financial Report
25/02/09	PRICE SENSITIVE	393.26KB	Share
CGSStrategic Relationship Update
18/02/09	PRICE SENSITIVE	253.39KB	Share
CGSAppendix 4C - quarterly
28/01/09	PRICE SENSITIVE	184.69KB	Share

REFRESH

First 2

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last $2.02		Change 0.020(1.00%)		Mkt cap ! $345.8M

Open	High	Low	Value	Volume
$2.00	$2.07	$1.98	$509.1K	251.9K

Buyers (Bids)

No.	Vol.	Price($)
1	10000	$2.01

Sellers (Offers)

Price($)	Vol.	No.
$2.02	22222	1

View Market Depth

No.	Vol.	Price($)
1	10000	2.010
1	1000	2.000
1	5050	1.980
2	13257	1.950
1	5000	1.910

Price($)	Vol.	No.
2.020	22222	1
2.100	611	1
2.120	2000	1
2.190	3341	1
2.200	5900	2

Last trade - 16.10pm 19/09/2025 (20 minute delay)


Last $2.02		Change 0.020 ( 0.85 %)
Open	High	Low	Volume
$2.00	$2.07	$1.98	21288
Last updated 15.35pm 19/09/2025 ?

CGS (ASX) Chart

COGSTATE LTD - Announcements

Corporate SpotlightNot Yet Available

Announcements

Buyers (Bids)

Sellers (Offers)

Top Stories

Corporate Spotlight
Not Yet Available